SCHEMBL4558484

SCHEMBL4558484

CC(=O)ON1C(=O)NC(=O)C1(C)c1cc(F)cc(F)c1

nearest known ligand 0.35

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HCAR3 P49019 1/20 0.35
HCAR2 Q8TDS4 1/20 0.35
CHRNA1 P02708 1/20 0.31
CHRNG P07510 1/20 0.31
CHRNB1 P11230 1/20 0.31
CHRNB2 P17787 1/20 0.31
SLC6A2 P23975 1/20 0.31
CHRNB4 P30926 1/20 0.31
CHRNA3 P32297 1/20 0.31
CHRNA4 P43681 1/20 0.31
SLC6A3 Q01959 1/20 0.31
CHRND Q07001 1/20 0.31
AKR1B1 P15121 1/20 0.31
APP P05067 1/20 0.31
BACE1 P56817 1/20 0.31
ADAMTS5 Q9UNA0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid Methyl Ester SCHEMBL28071128 0.61 ALDH1A1 (0.56) SLC6A3
SCHEMBL25290950 0.58 AR (0.53) AKR1B1ADAMTS5
Acetic Acid SCHEMBL27478470 0.58 CES2 (0.55) HCAR3HCAR2SLC6A3
SCHEMBL25564135 0.57 DRD2 (0.37) HCAR3HCAR2CHRNA1CHRNGCHRNB1
SCHEMBL25564311 0.56 HDAC3 (0.37) HCAR3HCAR2CHRNA1CHRNGCHRNB1
SCHEMBL25564314 0.56 HDAC3 (0.37) HCAR3HCAR2CHRNA1CHRNGCHRNB1
SCHEMBL25564232 0.56 HDAC3 (0.37) HCAR3HCAR2CHRNA1CHRNGCHRNB1
SCHEMBL1995396 0.56 CYP4F2 (0.69) BACE1
SCHEMBL1960996 0.56 CES2 (0.38) HCAR3HCAR2CHRNA1CHRNGCHRNB1
SCHEMBL10246211 0.55 BACE1 (0.44) HCAR3HCAR2APPBACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2134342-A2 MONOCYCLIC ANILIDE SPIROLACTAM CGRP RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 2009-12-23 EP disclosed
WO-2008112159-A2 MONOCYCLIC ANILIDE SPIROLACTAM CGRP RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 2008-09-18 WO disclosed